Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
EU keurt langwerkende injecteerbare hiv-behandeling voor adolescenten goed
feb 2025 | HIV, Virale infecties